ZA827133B - Dioximino cephalosporin antibiotics - Google Patents

Dioximino cephalosporin antibiotics

Info

Publication number
ZA827133B
ZA827133B ZA827133A ZA827133A ZA827133B ZA 827133 B ZA827133 B ZA 827133B ZA 827133 A ZA827133 A ZA 827133A ZA 827133 A ZA827133 A ZA 827133A ZA 827133 B ZA827133 B ZA 827133B
Authority
ZA
South Africa
Prior art keywords
dioximino
cephalosporin antibiotics
cephalosporin
antibiotics
dioximino cephalosporin
Prior art date
Application number
ZA827133A
Other languages
English (en)
Inventor
Henry Walker Lunn William
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA827133B publication Critical patent/ZA827133B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA827133A 1981-10-02 1982-09-29 Dioximino cephalosporin antibiotics ZA827133B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/307,983 US4402955A (en) 1981-10-02 1981-10-02 Dioximino cephalosporin antibiotics

Publications (1)

Publication Number Publication Date
ZA827133B true ZA827133B (en) 1984-05-30

Family

ID=23192021

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA827133A ZA827133B (en) 1981-10-02 1982-09-29 Dioximino cephalosporin antibiotics

Country Status (12)

Country Link
US (1) US4402955A (de)
JP (1) JPS5869888A (de)
AU (1) AU8891882A (de)
BE (1) BE894563A (de)
DE (1) DE3236065A1 (de)
FR (1) FR2514004B1 (de)
GB (1) GB2106905B (de)
IL (1) IL66888A0 (de)
IT (1) IT1157330B (de)
NL (1) NL8203807A (de)
NZ (1) NZ202034A (de)
ZA (1) ZA827133B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
ZA804670B (en) * 1979-08-03 1981-07-29 Beecham Group Ltd Derivatives of clavulanic acid, a process for their preparation and their use
NZ199061A (en) * 1980-12-09 1984-10-19 Beecham Group Ltd 9-(n-tetrazolyl)-deoxyclavulanic acids,salts,esters,and pharmaceutical compositions
US4562182A (en) * 1980-12-23 1985-12-31 Beecham Group P.L.C. Compounds containing beta-lactams
US4450270A (en) * 1981-10-02 1984-05-22 Eli Lilly And Company Dioximino cephalosporin antibiotics
DE3247614A1 (de) * 1982-12-23 1984-07-05 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3316798A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
GB8519606D0 (en) * 1985-08-05 1985-09-11 Fujisawa Pharmaceutical Co 3 7-d substituted-3-cephem compounds
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
MX352760B (es) 2011-09-09 2017-12-07 Merck Sharp & Dohme Corp Star Metodos para tratar infecciones intrapulmonares.
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2760484C2 (de) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
JPS609719B2 (ja) * 1977-08-06 1985-03-12 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
IT1192287B (it) * 1977-11-14 1988-03-31 Fujisawa Pharmaceutical Co Derivati di acido cefalosporanico ad azione farmaceutica e relativo procedimento di preparazione
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
GR75644B (de) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
IT8223566A0 (it) 1982-09-30
AU8891882A (en) 1983-04-14
FR2514004B1 (fr) 1986-04-18
US4402955A (en) 1983-09-06
GB2106905A (en) 1983-04-20
NL8203807A (nl) 1983-05-02
BE894563A (fr) 1983-03-30
DE3236065A1 (de) 1983-04-14
FR2514004A1 (fr) 1983-04-08
GB2106905B (en) 1985-05-15
IT1157330B (it) 1987-02-11
IL66888A0 (en) 1982-12-31
NZ202034A (en) 1985-09-13
JPS5869888A (ja) 1983-04-26

Similar Documents

Publication Publication Date Title
GB2094309B (en) Cephalosporin antibiotics
GB2106905B (en) Dioximino cephalosporin antibiotics
GB2123414B (en) Cephalosporin antibiotics
GB2084144B (en) Bis-tetrazoylmethyl substituted cephalosporin antibiotics
GB2132193B (en) Cephalosporin antibiotics
AU7959382A (en) Cephalosporin antibiotics
ZA833616B (en) Cephalosporin antibiotics
GB8317618D0 (en) Cephalosporin antibiotics
ZA825707B (en) Beta-lactam antibiotics
AU8851082A (en) Cephalosporin antibiotics
IL69109A0 (en) Cephalosporin antibiotics
IL69108A0 (en) Cephalosporin antibiotics
IE820546L (en) Cephalosporin antibiotics
AU8850982A (en) Cephalosporin antibiotics
GB8307584D0 (en) Cephalosporin antibiotics
IE831513L (en) Cephalosporin antibiotics
GB8315929D0 (en) Cephalosporin antibiotics
GB8315930D0 (en) Cephalosporin antibiotics
GB8334598D0 (en) Cephalosporin antibiotics
GB8334600D0 (en) Cephalosporin antibiotics
GB8334601D0 (en) Cephalosporin antibiotics
GB8334599D0 (en) Cephalosporin antibiotics
IE831514L (en) Cephalosporin antibiotics
GB8312676D0 (en) Cephalosporin antibiotics
GB8307587D0 (en) Cephalosporin antibiotics